Fenske, T K, Davis, P, Aaron, S L · Clinical and experimental rheumatology · 1994
This study examined 11 women who developed widespread pain, fatigue, and joint symptoms after receiving silicone breast implants. The researchers found that 6 patients met criteria for fibromyalgia and 5 had chronic fatigue syndrome symptoms, but none had evidence of a traditional autoimmune disease. The authors suggest these cases should be classified as CFS or fibromyalgia rather than a unique implant-related disease.
This study is significant because it documents overlap between ME/CFS, fibromyalgia, and post-implant symptoms, suggesting a potential environmental or immune trigger for multi-system symptoms. Understanding whether silicone exposure or other adjuvant exposures can precipitate CFS-like illness could have broader implications for identifying CFS triggers and pathogenic mechanisms.
This study does not prove that silicone implants cause CFS or fibromyalgia—it only describes 11 cases with temporal association, which is insufficient to establish causation. The authors themselves avoid claiming implants are the cause, and the small sample size and lack of comparison groups (control patients without implants) mean alternative explanations cannot be ruled out.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →